Responses
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0202 Clinical Outcomes of Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in The Open-Label Long-Term Extension
Compose a Response to This Article
Other responses
No responses have been published for this article.